137 related articles for article (PubMed ID: 34057203)
1. Association between PDCD1 gene polymorphisms and psoriasis susceptibility in the Chinese population.
Hua S; Fan B; Mao W; Xu R; Wang Y; Kuai L; Ding X; Li B; Chen J; Miao X
Int J Dermatol; 2021 Nov; 60(11):1411-1417. PubMed ID: 34057203
[TBL] [Abstract][Full Text] [Related]
2. Effects of the programmed cell death 1 (PDCD1) polymorphisms in susceptibility to systemic lupus erythematosus.
Fathi F; Sadeghi E; Lotfi N; Hafezi H; Ahmadi M; Mozafarpoor S; Motedayyen H
Int J Immunogenet; 2020 Feb; 47(1):57-64. PubMed ID: 31565862
[TBL] [Abstract][Full Text] [Related]
3. Programmed cell death 1 (PDCD1) gene haplotypes and susceptibility of patients to basal cell carcinoma.
Fathi F; Zamani B; Piroozmand A; Mozafarpoor S; Seyedhashemi E; ArefNezhad R; Motedayyen H
Mol Biol Rep; 2021 Mar; 48(3):2047-2052. PubMed ID: 33389528
[TBL] [Abstract][Full Text] [Related]
4. Association between PDCD1 Gene Polymorphisms and Risk of Systemic Lupus Erythematosus in Three Main Ethnic Groups of the Malaysian Population.
Chua KH; Lian LH; Sim XJ; Cheah TE; Lau TP
Int J Mol Sci; 2015 Apr; 16(5):9794-803. PubMed ID: 25938972
[TBL] [Abstract][Full Text] [Related]
5. Association of programmed death-1 gene polymorphisms with the risk of basal cell carcinoma.
Fathi F; Ebrahimi M; Eslami A; Hafezi H; Eskandari N; Motedayyen H
Int J Immunogenet; 2019 Dec; 46(6):444-450. PubMed ID: 31293069
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of programmed cell death 1 polymorphisms with systemic lupus erythematosus risk.
Gao J; Gai N; Wang L; Liu K; Liu XH; Wei LT; Tian T; Li SL; Zheng Y; Deng YJ; Dai ZJ; Fu RG
Oncotarget; 2017 May; 8(22):36885-36897. PubMed ID: 28415570
[TBL] [Abstract][Full Text] [Related]
7. Association of PDCD1 with susceptibility to systemic lupus erythematosus: evidence of population-specific effects.
Ferreiros-Vidal I; Gomez-Reino JJ; Barros F; Carracedo A; Carreira P; Gonzalez-Escribano F; Liz M; Martin J; Ordi J; Vicario JL; Gonzalez A
Arthritis Rheum; 2004 Aug; 50(8):2590-7. PubMed ID: 15334473
[TBL] [Abstract][Full Text] [Related]
8. [The analysis on single nucleotide polymorphism of PDCD1 and systemic lupus erythematous susceptibility among Han indigenous in Chinese population].
Ye DQ; Yin J; Li XP; Zhang GQ; Zhang YQ; Wang Q; Liu HH
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Sep; 26(9):698-701. PubMed ID: 16471222
[TBL] [Abstract][Full Text] [Related]
9. Lack of association of programmed cell death 1 gene (PDCD1) polymorphisms with susceptibility to chronic urticaria in patients with positive autologous serum skin test.
Brzoza Z; Grzeszczak W; Trautsolt W; Moczulski D
J Investig Allergol Clin Immunol; 2012; 22(6):432-6. PubMed ID: 23101188
[TBL] [Abstract][Full Text] [Related]
10. Association of PDCD1 polymorphisms with childhood-onset systemic lupus erythematosus.
Velázquez-Cruz R; Orozco L; Espinosa-Rosales F; Carreño-Manjarrez R; Solís-Vallejo E; López-Lara ND; Ruiz-López IK; Rodríguez-Lozano AL; Estrada-Gil JK; Jiménez-Sánchez G; Baca V
Eur J Hum Genet; 2007 Mar; 15(3):336-41. PubMed ID: 17228327
[TBL] [Abstract][Full Text] [Related]
11. PDCD1 single nucleotide genes polymorphisms confer susceptibility to juvenile-onset systemic lupus erythematosus.
Mahmoudi M; Rezaiemanesh A; Salmaninejad A; Harsini S; Poursani S; Bahrami T; Tahghighi F; Ziaee V; Rezaei N
Autoimmunity; 2015; 48(7):488-93. PubMed ID: 26108738
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of genetic polymorphisms in programmed cell death 1. Associations with rheumatoid arthritis, ankylosing spondylitis, and type 1 diabetes susceptibility.
Lee YH; Bae SC; Kim JH; Song GG
Z Rheumatol; 2015 Apr; 74(3):230-9. PubMed ID: 24942602
[TBL] [Abstract][Full Text] [Related]
13. PDCD1 gene polymorphisms as regulators of T-lymphocyte activity in cutaneous melanoma risk and prognosis.
Gomez GVB; Rinck-Junior JA; Oliveira C; Silva DHL; Mamoni RL; Lourenço GJ; Moraes AM; Lima CSP
Pigment Cell Melanoma Res; 2018 Mar; 31(2):308-317. PubMed ID: 29090522
[TBL] [Abstract][Full Text] [Related]
14. PDCD1 and CTLA4 polymorphisms affect the susceptibility to, and clinical features of, chronic immune thrombocytopenia.
Kasamatsu T; Ino R; Takahashi N; Gotoh N; Minato Y; Takizawa M; Yokohama A; Handa H; Saitoh T; Tsukamoto N; Murakami H
Br J Haematol; 2018 Mar; 180(5):705-714. PubMed ID: 29359792
[TBL] [Abstract][Full Text] [Related]
15. PDCD1 and PDCD1LG1 polymorphisms affect the susceptibility to multiple myeloma.
Kasamatsu T; Awata M; Ishihara R; Murakami Y; Gotoh N; Matsumoto M; Sawamura M; Yokohama A; Handa H; Tsukamoto N; Saitoh T; Murakami H
Clin Exp Med; 2020 Feb; 20(1):51-62. PubMed ID: 31620907
[TBL] [Abstract][Full Text] [Related]
16. The Association of Programmed Death 1 Gene Polymorphisms of PD1.3 G/A and PD1.5 C/T with Risk of COVID-19 in an Iranian Population: A Case-Control Study.
Rayati Damavandi A; Zolfaghari Baghbadorani P; Kardideh B; Fouladseresht H; Golabi M; Ghezelbash B; Andalib S; Eskandari N; Mirniam SM; Fathi F
Viral Immunol; 2022 May; ():. PubMed ID: 35512734
[TBL] [Abstract][Full Text] [Related]
17. Programmed cell death 1 gene polymorphism as a possible risk for systemic lupus erythematosus in Egyptian females.
Abo El-Khair SM; Sameer W; Awadallah N; Shaalan D
Lupus; 2019 Oct; 28(12):1427-1434. PubMed ID: 31551030
[TBL] [Abstract][Full Text] [Related]
18. Rs2227982 and rs2227981 in PDCD1 gene are functional SNPs associated with T1D risk in East Asian.
Gu Y; Xiao L; Gu W; Chen S; Feng Y; Wang J; Wang Z; Cai Y; Chen H; Xu X; Shi Y; Zhang M; Xu K; Yang T
Acta Diabetol; 2018 Aug; 55(8):813-819. PubMed ID: 29774466
[TBL] [Abstract][Full Text] [Related]
19. Association of PDCD1 polymorphism to systemic lupus erythematosus and rheumatoid arthritis susceptibility.
do Canto LM; Farias TD; Medeiros MD; Coêlho CC; Sereia AF; de Carlos Back LK; de Mello FM; Zimmermann AF; Pereira IA; de Souza IR
Rev Bras Reumatol Engl Ed; 2016; 56(6):483-489. PubMed ID: 27914594
[TBL] [Abstract][Full Text] [Related]
20. Lack of association between CTLA-4 and PDCD1 polymorphisms and acute rejection in German liver transplant recipients.
Thude H; Schipler AD; Treszl A; Peine S; Koch M; Sterneck M; Nashan B
Hum Immunol; 2013 Aug; 74(8):1041-5. PubMed ID: 23628397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
